|
| Status |
Public on Mar 18, 2015 |
| Title |
Preclinical antitumor activity of ST7612AA1: a novel second generation oral histone deacetylase (HDAC) inhibitor |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by array
|
| Summary |
assess the efficacy of ST7612AA1 oral pan-histone deacetylase inhibitor (HDACi), with respect to various solid and haematological tumors, and to characterize its mechanism of action
|
| |
|
| Overall design |
GEP analysis of two lymphoma cell lines with and without treatment
|
| |
|
| Contributor(s) |
Bernasconi E, Rinaldi A, Vesci L, Kwee I, Bertoni F |
| Citation(s) |
25671299 |
| |
| Submission date |
Oct 17, 2014 |
| Last update date |
Aug 13, 2018 |
| Contact name |
Francesco Bertoni |
| E-mail(s) |
francesco.bertoni@ior.usi.ch
|
| Phone |
+41 91 820 0367
|
| Organization name |
IOR
|
| Department |
Lymphoma & Genomics Research Program
|
| Street address |
Via V. Vela 6
|
| City |
Bellinzona |
| State/province |
Ticino |
| ZIP/Postal code |
6500 |
| Country |
Switzerland |
| |
|
| Platforms (1) |
| GPL10558 |
Illumina HumanHT-12 V4.0 expression beadchip |
|
| Samples (12)
|
|
| Relations |
| BioProject |
PRJNA264171 |
Less...
More...